565 related articles for article (PubMed ID: 12429198)
1. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
Li Q; Stephenson D
Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
[TBL] [Abstract][Full Text] [Related]
2. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M
J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649
[TBL] [Abstract][Full Text] [Related]
3. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.
Fisher M; Meadows ME; Do T; Weise J; Trubetskoy V; Charette M; Finklestein SP
J Cereb Blood Flow Metab; 1995 Nov; 15(6):953-9. PubMed ID: 7593356
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
5. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.
Tatlisumak T; Takano K; Carano RA; Fisher M
Stroke; 1996 Dec; 27(12):2292-7; discussion 2298. PubMed ID: 8969796
[TBL] [Abstract][Full Text] [Related]
6. Intravenous basic fibroblast growth factor produces a persistent reduction in infarct volume following permanent focal ischemia in rats.
Sugimori H; Speller H; Finklestein SP
Neurosci Lett; 2001 Mar; 300(1):13-6. PubMed ID: 11172928
[TBL] [Abstract][Full Text] [Related]
7. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat.
Kawamata T; Alexis NE; Dietrich WD; Finklestein SP
J Cereb Blood Flow Metab; 1996 Jul; 16(4):542-7. PubMed ID: 8964792
[TBL] [Abstract][Full Text] [Related]
8. Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia.
Ren JM; Finklestein SP
Eur J Pharmacol; 1997 May; 327(1):11-6. PubMed ID: 9185830
[TBL] [Abstract][Full Text] [Related]
9. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.
Britton P; Lu XC; Laskosky MS; Tortella FC
Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model.
Tanaka R; Miyasaka Y; Yada K; Ohwada T; Kameya T
Stroke; 1995 Nov; 26(11):2154-8; discussion 2158-9. PubMed ID: 7482665
[TBL] [Abstract][Full Text] [Related]
11. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
12. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
13. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia.
Schäbitz WR; Li F; Irie K; Sandage BW; Locke KW; Fisher M
Stroke; 1999 Feb; 30(2):427-31; discussion 431-2. PubMed ID: 9933283
[TBL] [Abstract][Full Text] [Related]
15. bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice.
Huang Z; Chen K; Huang PL; Finklestein SP; Moskowitz MA
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1401-5. PubMed ID: 9087617
[TBL] [Abstract][Full Text] [Related]
16. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
Sayeed I; Wali B; Stein DG
Restor Neurol Neurosci; 2007; 25(2):151-9. PubMed ID: 17726274
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH
J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
19. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia.
Liu R; Wang X; Liu Q; Yang SH; Simpkins JW
Neurosci Lett; 2007 Mar; 415(3):237-41. PubMed ID: 17331646
[TBL] [Abstract][Full Text] [Related]
20. Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats.
Lee EJ; Wu TS; Chang GL; Li CY; Chen TY; Lee MY; Chen HY; Maynard KI
Curr Neurovasc Res; 2006 Aug; 3(3):203-13. PubMed ID: 16918384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
